This activity is designed for physicians, physician assistants, nurse practitioners, nurses, and other healthcare professionals to align with the Commission on Cancer Standards. This multidisciplinary team of specialists aims to enhance educational support through proactive discussions on Thoracic related cancer diagnoses, treatment options, and postoperative outcomes for both adult and pediatric patients. The program addresses gaps such as the absence of the latest NCCN and LCI guidelines, lack of multidisciplinary treatment plans, and outdated AJCC cancer staging.
Course Director:
- Jeffrey Hagen, MD
Overall Objectives:
- Assess discussion of the TNM Cancer staging of thoracic cancer patients that are presented at this series.
- Analyze the execution of the NCCN (& LCI) guidelines for all thoracic cancer patients presented at this event.
- Review advanced information of available treatments to improve outcomes of the thoracic cancer patients presented at this event.
Target Audience:
This activity is designed for physicians and other healthcare professionals.
Accreditation Statement
In support of improving patient care, Advocate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Statement(s)
American Medical Association (AMA)
Advocate Health designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Board Recognition Statement(s)
American Board of Surgery (ABS)
Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.